Nrf2 has been extensively studied in bladder as a defender against tobacco carcinogens [35, 36]; conversely, Nrf2 may also protect bladder cancer cells against reactive oxygen species and promote resistance to chemotherapeutic agents [37, 38]. Here, NFE2L2 is linked to urinary bladder carcinoma.